Skip to main content
Premium Trial:

Request an Annual Quote

Lion s Revenues Decline Sharply in Q2 of FY05, Loss Narrows

NEW YORK, Nov. 4 (GenomeWeb News) - Lion Bioscience today reported a sharp revenue downturn for its second fiscal quarter, while the company cut its loss in half.


Lion booked €2.6 million ($3.4 million) in revenues for the quarter ended Sept. 30, down from €5 million ($6.4 million) during the same period last year.


The company did not state its R&D expenses for the quarter.


Lion's net loss for the quarter narrowed to €3.4 million from €6.5 million during the year-ago quarter. This reduction resulted from Lion's cost-cutting measures.


As of Sept. 30, Lion had €33.3 million in liquid assets.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.